The Global Oncology Academy (GOA) is an educational platform for physicians and other healthcare professionals involved in oncology. Its mission is to increase knowledge regarding the disease course of specific cancers and address key elements for successful management. The GOA series will also share the science around innovations in combination therapies, oncology strategies, and new developments.
For more information about GOA, visit www.globaloncologyacademy.org.
Optimal Sequencing of ADCs in Endocrine Refractory HR+/HER2- Metastatic Breast Cancer
Optimal Sequencing of ADCs in Endocrine Refractory HR+/HER2- Metastatic Breast Cancer
ATTRv-PN: A Complicated Disease With a Poor Prognosis
ATTRv-PN: A Complicated Disease With a Poor Prognosis
Advancing the Treatment of ATTRv-PN: What's in the Pipeline?
Advancing the Treatment of ATTRv-PN: What's in the Pipeline?
Raising the Red Flag: What's Your Index of Suspicion for ATTRv-PN?
Raising the Red Flag: What's Your Index of Suspicion for ATTRv-PN?
Cracking the CRS Code in Myeloma: Insights from a Comprehensive Case Review
Cracking the CRS Code in Myeloma: Insights from a Comprehensive Case Review
A Roadmap to Safe and Effective Bispecific Antibody Use in Myeloma: Mitigating and Managing Adverse Events
A Roadmap to Safe and Effective Bispecific Antibody Use in Myeloma: Mitigating and Managing Adverse Events
Approved Bispecific Antibodies for RRMM: Review of the Pivotal Trials
Approved Bispecific Antibodies for RRMM: Review of the Pivotal Trials
Managing Infections, Cytopenias, and Other AEs Related to Bispecific Antibodies
Managing Infections, Cytopenias, and Other AEs Related to Bispecific Antibodies
Efficacy Data for Bispecific Antibodies in RRMM
Efficacy Data for Bispecific Antibodies in RRMM